[Efficacy and safety of IAC regimen for relapse/refractory acute myeloid leukemia: a prospective randomized controlled study].
Li CH, Wei SN, Qiu SW, Gong BF, Gong XY, Li Y, Liu YT, Fang QY, Zhang GJ, Liu KQ, Zhou CL, Lin D, Liu BC, Wang Y, Mi YC, Wei H, Wang JX.
Li CH, et al. Among authors: wei sn.
Zhonghua Xue Ye Xue Za Zhi. 2022 Apr 14;43(4):287-292. doi: 10.3760/cma.j.issn.0253-2727.2022.04.004.
Zhonghua Xue Ye Xue Za Zhi. 2022.
PMID: 35680626
Free PMC article.
Clinical Trial.
Chinese.